Cefepime/VNRX-5133

cefepime + VNRX-5133 · Venatorx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cefepime/VNRX-5133, covering 2024-05-29 to 2024-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections [Phase 3]